AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...

However, significant barriers stand in the way of realising this promise on a worldwide scale, from manufacturing costs and ...

Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based ...

Louise Digby, vice president of enzymes and bioproduction at BioProduction by SEKISUI, discusses some of the current ...

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

With increasing demand for cell and gene therapies, mesenchymal stem cells (MSCs) have gained attention for their versatility ...

The therapy can cost anywhere between $350,000 and $700,000 globally. While Immuneel has brought it down to about ₹51 lakh to ...

Moreover, the high costs associated with gene therapy production and the complex manufacturing process could further pressure profit margins if economies of scale are not achieved quickly. The slow ...

Moreover, the high costs associated with gene therapy production and the complex manufacturing process could further pressure profit margins if economies of scale are not achieved quickly.